{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:02:37Z","timestamp":1791586957596,"version":"4.3.4"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s40291-022-00600-7","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T10:06:55Z","timestamp":1656324415000},"page":"483-495","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Modern Biomarkers for Autism Spectrum Disorder: Future Directions"],"prefix":"10.1007","volume":"26","author":[{"given":"Amanda R.","family":"Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison L.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna A.","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sallie E.","family":"McLees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa S.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4442-2937","authenticated-orcid":false,"given":"Richard E.","family":"Frye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,27]]},"reference":[{"issue":"11","key":"600_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss7011a1","volume":"70","author":"MJ Maenner","year":"2021","unstructured":"Maenner MJ, et al. Prevalence and characteristics of autism spectrum disorder among children aged 8 years: Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2018. MMWR Surveill Summ. 2021;70(11):1\u201316.","journal-title":"MMWR Surveill Summ"},{"issue":"3","key":"600_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","volume":"69","author":"Biomarkers Definitions Working Group","year":"2001","unstructured":"Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89\u201395.","journal-title":"Clin Pharmacol Ther"},{"issue":"23","key":"600_CR3","doi-asserted-by":"publisher","first-page":"792","DOI":"10.21037\/atm.2019.11.53","volume":"7","author":"RE Frye","year":"2019","unstructured":"Frye RE, et al. Emerging biomarkers in autism spectrum disorder: a systematic review. Ann Transl Med. 2019;7(23):792.","journal-title":"Ann Transl Med."},{"issue":"3","key":"600_CR4","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3390\/jpm12030464","volume":"12","author":"RE Frye","year":"2022","unstructured":"Frye RE. A personalized multidisciplinary approach to evaluating and treating autism spectrum disorder. J Pers Med. 2022;12(3):464.","journal-title":"J Pers Med."},{"issue":"4","key":"600_CR5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/mp.2011.165","volume":"17","author":"DA Rossignol","year":"2012","unstructured":"Rossignol DA, Frye RE. A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry. 2012;17(4):389\u2013401.","journal-title":"Mol Psychiatry"},{"key":"600_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.bbi.2016.06.005","volume":"58","author":"HY Jiang","year":"2016","unstructured":"Jiang HY, et al. Maternal infection during pregnancy and risk of autism spectrum disorders: a systematic review and meta-analysis. Brain Behav Immun. 2016;58:165\u201372.","journal-title":"Brain Behav Immun"},{"issue":"3","key":"600_CR7","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/mp.2017.119","volume":"23","author":"M Hornig","year":"2018","unstructured":"Hornig M, et al. Prenatal fever and autism risk. Mol Psychiatry. 2018;23(3):759\u201366.","journal-title":"Mol Psychiatry"},{"issue":"12","key":"600_CR8","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1007\/s10803-013-2016-3","volume":"45","author":"O Zerbo","year":"2015","unstructured":"Zerbo O, et al. Maternal infection during pregnancy and autism spectrum disorders. J Autism Dev Disord. 2015;45(12):4015\u201325.","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"600_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10803-012-1540-x","volume":"43","author":"O Zerbo","year":"2013","unstructured":"Zerbo O, et al. Is maternal influenza or fever during pregnancy associated with autism or developmental delays? Results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) study. J Autism Dev Disord. 2013;43(1):25\u201333.","journal-title":"J Autism Dev Disord"},{"key":"600_CR10","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.bbi.2014.09.001","volume":"44","author":"BK Lee","year":"2015","unstructured":"Lee BK, et al. Maternal hospitalization with infection during pregnancy and risk of autism spectrum disorders. Brain Behav Immun. 2015;44:100\u20135.","journal-title":"Brain Behav Immun"},{"issue":"11","key":"600_CR11","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1002\/aur.1841","volume":"10","author":"M Brucato","year":"2017","unstructured":"Brucato M, et al. Prenatal exposure to fever is associated with autism spectrum disorder in the boston birth cohort. Autism Res. 2017;10(11):1878\u201390.","journal-title":"Autism Res"},{"issue":"3","key":"600_CR12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.it.2022.01.007","volume":"43","author":"HK Kwon","year":"2022","unstructured":"Kwon HK, Choi GB, Huh JR. Maternal inflammation and its ramifications on fetal neurodevelopment. Trends Immunol. 2022;43(3):230\u201344.","journal-title":"Trends Immunol"},{"issue":"8","key":"600_CR13","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/aur.1586","volume":"9","author":"N Connolly","year":"2016","unstructured":"Connolly N, et al. Maternal metabolic risk factors for autism spectrum disorder: an analysis of electronic medical records and linked birth data. Autism Res. 2016;9(8):829\u201337.","journal-title":"Autism Res"},{"issue":"3","key":"600_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3390\/jpm11030218","volume":"11","author":"RE Frye","year":"2021","unstructured":"Frye RE, et al. Mitochondria may mediate prenatal environmental influences in autism spectrum disorder. J Pers Med. 2021;11(3):218.","journal-title":"J Pers Med."},{"issue":"5","key":"600_CR15","doi-asserted-by":"publisher","first-page":"e1121","DOI":"10.1542\/peds.2011-2583","volume":"129","author":"P Krakowiak","year":"2012","unstructured":"Krakowiak P, et al. Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders. Pediatrics. 2012;129(5):e1121\u20138.","journal-title":"Pediatrics"},{"issue":"18","key":"600_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006696","volume":"96","author":"C Wang","year":"2017","unstructured":"Wang C, et al. Prenatal, perinatal, and postnatal factors associated with autism: a meta-analysis. Medicine (Baltimore). 2017;96(18): e6696.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"600_CR17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/ijms17020180","volume":"17","author":"GB Schaefer","year":"2016","unstructured":"Schaefer GB. Clinical genetic aspects of ASD spectrum disorders. Int J Mol Sci. 2016;17(2):180.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"600_CR18","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3390\/jpm11090848","volume":"11","author":"PS Gill","year":"2021","unstructured":"Gill PS, et al. Molecular dysregulation in autism spectrum disorder. J Pers Med. 2021;11(9):848.","journal-title":"J Pers Med."},{"issue":"5","key":"600_CR19","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/gim.2013.32","volume":"15","author":"GB Schaefer","year":"2013","unstructured":"Schaefer GB, et al. Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genet Med. 2013;15(5):399\u2013407.","journal-title":"Genet Med"},{"issue":"9","key":"600_CR20","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1001\/jama.2015.10078","volume":"314","author":"K Tammimies","year":"2015","unstructured":"Tammimies K, et al. Molecular diagnostic yield of chromosomal microarray analysis and whole-exome sequencing in children with autism spectrum disorder. JAMA. 2015;314(9):895\u2013903.","journal-title":"JAMA"},{"issue":"5","key":"600_CR21","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.ajhg.2017.09.008","volume":"101","author":"FF Hamdan","year":"2017","unstructured":"Hamdan FF, et al. High rate of recurrent de novo mutations in developmental and epileptic encephalopathies. Am J Hum Genet. 2017;101(5):664\u201385.","journal-title":"Am J Hum Genet"},{"key":"600_CR22","doi-asserted-by":"publisher","first-page":"5595","DOI":"10.1038\/ncomms6595","volume":"5","author":"BJ O'Roak","year":"2014","unstructured":"O\u2019Roak BJ, et al. Recurrent de novo mutations implicate novel genes underlying simplex autism risk. Nat Commun. 2014;5:5595.","journal-title":"Nat Commun"},{"issue":"1","key":"600_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13229-020-00382-x","volume":"11","author":"L Wang","year":"2020","unstructured":"Wang L, et al. Functional relationships between recessive inherited genes and genes with de novo variants in autism spectrum disorder. Mol Autism. 2020;11(1):75.","journal-title":"Mol Autism."},{"issue":"1","key":"600_CR24","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.1038\/s41467-020-18723-y","volume":"11","author":"T Wang","year":"2020","unstructured":"Wang T, et al. Large-scale targeted sequencing identifies risk genes for neurodevelopmental disorders. Nat Commun. 2020;11(1):4932.","journal-title":"Nat Commun"},{"issue":"5","key":"600_CR25","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ajhg.2020.04.004","volume":"106","author":"SM Myers","year":"2020","unstructured":"Myers SM, et al. Insufficient evidence for \u201cautism-specific\u201d genes. Am J Hum Genet. 2020;106(5):587\u201395.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"600_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/jgc4.1323","volume":"30","author":"A Yusuf","year":"2021","unstructured":"Yusuf A, et al. Adaptation and validation of the Genetic Counseling Outcome Scale for autism spectrum disorders and related conditions. J Genet Couns. 2021;30(1):305\u201318.","journal-title":"J Genet Couns"},{"key":"600_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.spen.2020.100804","volume":"34","author":"BL Kreiman","year":"2020","unstructured":"Kreiman BL, Boles RG. State of the art of genetic testing for patients with autism: a practical guide for clinicians. Semin Pediatr Neurol. 2020;34: 100804.","journal-title":"Semin Pediatr Neurol."},{"issue":"4","key":"600_CR28","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/mp.2012.126","volume":"19","author":"E Skafidas","year":"2014","unstructured":"Skafidas E, et al. Predicting the diagnosis of autism spectrum disorder using gene pathway analysis. Mol Psychiatry. 2014;19(4):504\u201310.","journal-title":"Mol Psychiatry"},{"issue":"3","key":"600_CR29","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/aur.2065","volume":"12","author":"S Qiu","year":"2019","unstructured":"Qiu S, et al. SHANK1 polymorphisms and SNP-SNP interactions among SHANK family: a possible cue for recognition to autism spectrum disorder in infant age. Autism Res. 2019;12(3):375\u201383.","journal-title":"Autism Res"},{"issue":"10","key":"600_CR30","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/j.freeradbiomed.2012.03.011","volume":"52","author":"A Frustaci","year":"2012","unstructured":"Frustaci A, et al. Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. Free Radic Biol Med. 2012;52(10):2128\u201341.","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"600_CR31","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3390\/ijms17050772","volume":"17","author":"NA Mahmuda","year":"2016","unstructured":"Mahmuda NA, et al. A study of single nucleotide polymorphisms of the SLC19A1\/RFC1 gene in subjects with autism spectrum disorder. Int J Mol Sci. 2016;17(5):772.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"600_CR32","doi-asserted-by":"publisher","first-page":"318","DOI":"10.21307\/ane-2017-030","volume":"76","author":"R Haghiri","year":"2016","unstructured":"Haghiri R, et al. Analysis of methionine synthase (rs1805087) gene polymorphism in autism patients in Northern Iran. Acta Neurobiol Exp (Wars). 2016;76(4):318\u201323.","journal-title":"Acta Neurobiol Exp (Wars)."},{"issue":"8","key":"600_CR33","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/ajmg.b.30366","volume":"141B","author":"SJ James","year":"2006","unstructured":"James SJ, et al. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet. 2006;141B(8):947\u201356.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"6","key":"600_CR34","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/ajmg.b.31094","volume":"153B","author":"SJ James","year":"2010","unstructured":"James SJ, et al. A functional polymorphism in the reduced folate carrier gene and DNA hypomethylation in mothers of children with autism. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(6):1209\u201320.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"6","key":"600_CR35","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/aur.156","volume":"3","author":"E Lerer","year":"2010","unstructured":"Lerer E, et al. Low CD38 expression in lymphoblastoid cells and haplotypes are both associated with autism in a family-based study. Autism Res. 2010;3(6):293\u2013302.","journal-title":"Autism Res"},{"key":"600_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2021.105290","volume":"131","author":"KM Krol","year":"2021","unstructured":"Krol KM, et al. Genetic variation in the oxytocin system and its link to social motivation in human infants. Psychoneuroendocrinology. 2021;131: 105290.","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"600_CR37","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3390\/jpm12040599","volume":"12","author":"PS Gill","year":"2022","unstructured":"Gill PS, et al. Multidisciplinary consulting team for complicated cases of neurodevelopmental and neurobehavioral disorders: assessing the opportunities and challenges of integrating pharmacogenomics into a team setting. J Pers Med. 2022;12(4):599.","journal-title":"J Pers Med."},{"issue":"3","key":"600_CR38","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3390\/pediatric13030049","volume":"13","author":"M Ariefdjohan","year":"2021","unstructured":"Ariefdjohan M, et al. The utility of pharmacogenetic-guided psychotropic medication selection for pediatric patients: a retrospective study. Pediatr Rep. 2021;13(3):421\u201333.","journal-title":"Pediatr Rep."},{"key":"600_CR39","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12887-016-0586-x","volume":"16","author":"SD Hicks","year":"2016","unstructured":"Hicks SD, et al. Salivary miRNA profiles identify children with autism spectrum disorder, correlate with adaptive behavior, and implicate ASD candidate genes involved in neurodevelopment. BMC Pediatr. 2016;16:52.","journal-title":"BMC Pediatr"},{"key":"600_CR40","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3389\/fgene.2018.00534","volume":"9","author":"SD Hicks","year":"2018","unstructured":"Hicks SD, et al. Validation of a salivary RNA test for childhood autism spectrum disorder. Front Genet. 2018;9:534.","journal-title":"Front Genet"},{"issue":"2","key":"600_CR41","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jaac.2019.03.017","volume":"59","author":"SD Hicks","year":"2020","unstructured":"Hicks SD, et al. Saliva MicroRNA differentiates children with autism from peers with typical and atypical development. J Am Acad Child Adolesc Psychiatry. 2020;59(2):296\u2013308.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"600_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.824933","volume":"12","author":"DQ Beversdorf","year":"2021","unstructured":"Beversdorf DQ, et al. Saliva RNA biomarkers of gastrointestinal dysfunction in children with autism and neurodevelopmental disorders: potential implications for precision medicine. Front Psychiatry. 2021;12: 824933.","journal-title":"Front Psychiatry."},{"issue":"7","key":"600_CR43","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrn.2016.41","volume":"17","author":"A Vogel Ciernia","year":"2016","unstructured":"Vogel Ciernia A, LaSalle J. The landscape of DNA methylation amid a perfect storm of autism aetiologies. Nat Rev Neurosci. 2016;17(7):411\u201323.","journal-title":"Nat Rev Neurosci"},{"key":"600_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.775390","volume":"14","author":"KM Bakulski","year":"2021","unstructured":"Bakulski KM, et al. Autism-associated DNA methylation at birth from multiple tissues is enriched for autism genes in the early autism risk longitudinal investigation. Front Mol Neurosci. 2021;14: 775390.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"600_CR45","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13148-020-00995-2","volume":"13","author":"N Garrido","year":"2021","unstructured":"Garrido N, et al. Sperm DNA methylation epimutation biomarker for paternal offspring autism susceptibility. Clin Epigenet. 2021;13(1):6.","journal-title":"Clin Epigenet"},{"issue":"24","key":"600_CR46","doi-asserted-by":"publisher","first-page":"9190","DOI":"10.3390\/ijerph17249190","volume":"17","author":"KM Bakulski","year":"2020","unstructured":"Bakulski KM, et al. Prenatal multivitamin use and MTHFR genotype are associated with newborn cord blood DNA methylation. Int J Environ Res Public Health. 2020;17(24):9190.","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"600_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033290","volume":"7","author":"JA McKay","year":"2012","unstructured":"McKay JA, et al. Genetic and non-genetic influences during pregnancy on infant global and site specific DNA methylation: role for folate gene variants and vitamin B12. PLoS ONE. 2012;7(3): e33290.","journal-title":"PLoS ONE"},{"issue":"1","key":"600_CR48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13073-018-0527-4","volume":"10","author":"E Hannon","year":"2018","unstructured":"Hannon E, et al. Elevated polygenic burden for autism is associated with differential DNA methylation at birth. Genome Med. 2018;10(1):19.","journal-title":"Genome Med."},{"issue":"4","key":"600_CR49","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/cercor\/bht294","volume":"25","author":"DL Dierker","year":"2015","unstructured":"Dierker DL, et al. Analysis of cortical shape in children with simplex autism. Cereb Cortex. 2015;25(4):1042\u201351.","journal-title":"Cereb Cortex"},{"issue":"7641","key":"600_CR50","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nature21369","volume":"542","author":"HC Hazlett","year":"2017","unstructured":"Hazlett HC, et al. Early brain development in infants at high risk for autism spectrum disorder. Nature. 2017;542(7641):348\u201351.","journal-title":"Nature"},{"issue":"4","key":"600_CR51","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1002\/aur.2083","volume":"12","author":"I Pote","year":"2019","unstructured":"Pote I, et al. Familial risk of autism alters subcortical and cerebellar brain anatomy in infants and predicts the emergence of repetitive behaviors in early childhood. Autism Res. 2019;12(4):614\u201327.","journal-title":"Autism Res"},{"issue":"1","key":"600_CR52","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1001\/archgenpsychiatry.2011.145","volume":"69","author":"CW Nordahl","year":"2012","unstructured":"Nordahl CW, et al. Increased rate of amygdala growth in children aged 2 to 4 years with autism spectrum disorders: a longitudinal study. Arch Gen Psychiatry. 2012;69(1):53\u201361.","journal-title":"Arch Gen Psychiatry"},{"key":"600_CR53","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.pnpbp.2013.09.010","volume":"48","author":"N Barnea-Goraly","year":"2014","unstructured":"Barnea-Goraly N, et al. A preliminary longitudinal volumetric MRI study of amygdala and hippocampal volumes in autism. Prog Neuropsychopharmacol Biol Psychiatry. 2014;48:124\u20138.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"6","key":"600_CR54","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1007\/s11682-018-9853-9","volume":"12","author":"Z Zhu","year":"2018","unstructured":"Zhu Z, et al. Alterations in volumes and MRI features of amygdala in Chinese autistic preschoolers associated with social and behavioral deficits. Brain Imaging Behav. 2018;12(6):1814\u201321.","journal-title":"Brain Imaging Behav"},{"issue":"11","key":"600_CR55","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S2215-0366(18)30294-3","volume":"5","author":"MD Shen","year":"2018","unstructured":"Shen MD, et al. Extra-axial cerebrospinal fluid in high-risk and normal-risk children with autism aged 2\u20134 years: a case-control study. Lancet Psychiatry. 2018;5(11):895\u2013904.","journal-title":"Lancet Psychiatry"},{"issue":"Pt 9","key":"600_CR56","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1093\/brain\/awt166","volume":"136","author":"MD Shen","year":"2013","unstructured":"Shen MD, et al. Early brain enlargement and elevated extra-axial fluid in infants who develop autism spectrum disorder. Brain. 2013;136(Pt 9):2825\u201335.","journal-title":"Brain"},{"issue":"6","key":"600_CR57","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1176\/appi.ajp.2011.11091447","volume":"169","author":"JJ Wolff","year":"2012","unstructured":"Wolff JJ, et al. Differences in white matter fiber tract development present from 6 to 24 months in infants with autism. Am J Psychiatry. 2012;169(6):589\u2013600.","journal-title":"Am J Psychiatry"},{"key":"600_CR58","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13229-017-0126-z","volume":"8","author":"JJ Wolff","year":"2017","unstructured":"Wolff JJ, et al. Neural circuitry at age 6 months associated with later repetitive behavior and sensory responsiveness in autism. Mol Autism. 2017;8:8.","journal-title":"Mol Autism."},{"issue":"1","key":"600_CR59","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11682-013-9245-0","volume":"8","author":"RM Joseph","year":"2014","unstructured":"Joseph RM, et al. Structural asymmetries of language-related gray and white matter and their relationship to language function in young children with ASD. Brain Imaging Behav. 2014;8(1):60\u201372.","journal-title":"Brain Imaging Behav"},{"issue":"12","key":"600_CR60","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.biopsych.2012.08.001","volume":"72","author":"L Walker","year":"2012","unstructured":"Walker L, et al. Diffusion tensor imaging in young children with autism: biological effects and potential confounds. Biol Psychiatry. 2012;72(12):1043\u201351.","journal-title":"Biol Psychiatry"},{"key":"600_CR61","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13229-018-0220-x","volume":"9","author":"OV Sysoeva","year":"2018","unstructured":"Sysoeva OV, Constantino JN, Anokhin AP. Event-related potential (ERP) correlates of face processing in verbal children with autism spectrum disorders (ASD) and their first-degree relatives: a family study. Mol Autism. 2018;9:41.","journal-title":"Mol Autism."},{"issue":"8","key":"600_CR62","first-page":"657","volume":"3","author":"E Kang","year":"2018","unstructured":"Kang E, et al. Atypicality of the N170 event-related potential in autism spectrum disorder: a meta-analysis. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018;3(8):657\u201366.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging."},{"issue":"5","key":"600_CR63","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/scan\/nsp002","volume":"7","author":"SJ Webb","year":"2012","unstructured":"Webb SJ, et al. ERP responses differentiate inverted but not upright face processing in adults with ASD. Soc Cogn Affect Neurosci. 2012;7(5):578\u201387.","journal-title":"Soc Cogn Affect Neurosci."},{"issue":"7","key":"600_CR64","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/aur.2505","volume":"14","author":"TC Parker","year":"2021","unstructured":"Parker TC, et al. The N170 event-related potential reflects delayed neural response to faces when visual attention is directed to the eyes in youths with ASD. Autism Res. 2021;14(7):1347\u201356.","journal-title":"Autism Res"},{"issue":"1","key":"600_CR65","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13229-021-00482-2","volume":"13","author":"F Shic","year":"2022","unstructured":"Shic F, et al. The autism biomarkers consortium for clinical trials: evaluation of a battery of candidate eye-tracking biomarkers for use in autism clinical trials. Mol Autism. 2022;13(1):15.","journal-title":"Mol Autism."},{"issue":"8","key":"600_CR66","first-page":"767","volume":"6","author":"ZJ Williams","year":"2021","unstructured":"Williams ZJ, et al. Cortical auditory processing of simple stimuli is altered in autism: a meta-analysis of auditory evoked responses. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021;6(8):767\u201381.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging."},{"issue":"1","key":"600_CR67","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s11689-021-09385-y","volume":"13","author":"TPL Roberts","year":"2021","unstructured":"Roberts TPL, Kuschner ES, Edgar JC. Biomarkers for autism spectrum disorder: opportunities for magnetoencephalography (MEG). J Neurodev Disord. 2021;13(1):34.","journal-title":"J Neurodev Disord"},{"issue":"1","key":"600_CR68","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13229-020-00357-y","volume":"11","author":"RA Seymour","year":"2020","unstructured":"Seymour RA, et al. Reduced auditory steady state responses in autism spectrum disorder. Mol Autism. 2020;11(1):56.","journal-title":"Mol Autism."},{"key":"600_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2021.787229","volume":"15","author":"TPL Roberts","year":"2021","unstructured":"Roberts TPL, et al. Magnetoencephalography studies of the envelope following response during amplitude-modulated sweeps: diminished phase synchrony in autism spectrum disorder. Front Hum Neurosci. 2021;15: 787229.","journal-title":"Front Hum Neurosci"},{"key":"600_CR70","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.nicl.2016.03.021","volume":"11","author":"RG Port","year":"2016","unstructured":"Port RG, et al. Maturation of auditory neural processes in autism spectrum disorder: a longitudinal MEG study. Neuroimage Clin. 2016;11:566\u201377.","journal-title":"Neuroimage Clin."},{"issue":"8","key":"600_CR71","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1001\/jamapsychiatry.2013.104","volume":"70","author":"LQ Uddin","year":"2013","unstructured":"Uddin LQ, et al. Salience network-based classification and prediction of symptom severity in children with autism. JAMA Psychiat. 2013;70(8):869\u201379.","journal-title":"JAMA Psychiat"},{"issue":"2","key":"600_CR72","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12264-017-0118-1","volume":"33","author":"D Li","year":"2017","unstructured":"Li D, Karnath HO, Xu Z. Candidate biomarkers in children with autism spectrum disorder: a review of MRI studies. Neurosci Bull. 2017;33(2):219\u201337.","journal-title":"Neurosci Bull"},{"issue":"3","key":"600_CR73","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1093\/cercor\/bhw403","volume":"27","author":"AT Eggebrecht","year":"2017","unstructured":"Eggebrecht AT, et al. Joint attention and brain functional connectivity in infants and toddlers. Cereb Cortex. 2017;27(3):1709\u201320.","journal-title":"Cereb Cortex"},{"issue":"1","key":"600_CR74","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41398-020-01178-6","volume":"11","author":"CS Hiremath","year":"2021","unstructured":"Hiremath CS, et al. Emerging behavioral and neuroimaging biomarkers for early and accurate characterization of autism spectrum disorders: a systematic review. Transl Psychiatry. 2021;11(1):42.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"600_CR75","first-page":"50","volume":"4","author":"CJ McKinnon","year":"2019","unstructured":"McKinnon CJ, et al. Restricted and repetitive behavior and brain functional connectivity in infants at risk for developing autism spectrum disorder. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019;4(1):50\u201361.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging."},{"issue":"Pt 3","key":"600_CR76","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/brain\/awr364","volume":"135","author":"LT Eyler","year":"2012","unstructured":"Eyler LT, Pierce K, Courchesne E. A failure of left temporal cortex to specialize for language is an early emerging and fundamental property of autism. Brain. 2012;135(Pt 3):949\u201360.","journal-title":"Brain"},{"issue":"2","key":"600_CR77","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1017\/S0954579419000233","volume":"32","author":"J Bradshaw","year":"2020","unstructured":"Bradshaw J, et al. Development of attention from birth to 5 months in infants at risk for autism spectrum disorder. Dev Psychopathol. 2020;32(2):491\u2013501.","journal-title":"Dev Psychopathol"},{"issue":"5","key":"600_CR78","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.tics.2018.02.012","volume":"22","author":"S Shultz","year":"2018","unstructured":"Shultz S, Klin A, Jones W. Neonatal transitions in social behavior and their implications for autism. Trends Cogn Sci. 2018;22(5):452\u201369.","journal-title":"Trends Cogn Sci"},{"issue":"7480","key":"600_CR79","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature12715","volume":"504","author":"W Jones","year":"2013","unstructured":"Jones W, Klin A. Attention to eyes is present but in decline in 2-6-month-old infants later diagnosed with autism. Nature. 2013;504(7480):427\u201331.","journal-title":"Nature"},{"issue":"1","key":"600_CR80","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13229-021-00476-0","volume":"12","author":"L Mason","year":"2021","unstructured":"Mason L, et al. Preference for biological motion is reduced in ASD: implications for clinical trials and the search for biomarkers. Mol Autism. 2021;12(1):74.","journal-title":"Mol Autism."},{"issue":"1","key":"600_CR81","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41398-020-01135-3","volume":"11","author":"L Chen","year":"2021","unstructured":"Chen L, et al. Oxidative stress marker aberrations in children with autism spectrum disorder: a systematic review and meta-analysis of 87 studies (N = 9109). Transl Psychiatry. 2021;11(1):15.","journal-title":"Transl Psychiatry"},{"key":"600_CR82","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1743-7075-9-35","volume":"9","author":"PA Main","year":"2012","unstructured":"Main PA, et al. The potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: a systematic review and meta-analysis. Nutr Metab (Lond). 2012;9:35.","journal-title":"Nutr Metab (Lond)"},{"issue":"23","key":"600_CR83","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.2174\/092986712802002572","volume":"19","author":"A Ghanizadeh","year":"2012","unstructured":"Ghanizadeh A, et al. Glutathione-related factors and oxidative stress in autism, a review. Curr Med Chem. 2012;19(23):4000\u20135.","journal-title":"Curr Med Chem"},{"issue":"7","key":"600_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.61","volume":"2","author":"S Rose","year":"2012","unstructured":"Rose S, et al. Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl Psychiatry. 2012;2(7): e134.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"600_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085436","volume":"9","author":"S Rose","year":"2014","unstructured":"Rose S, et al. Oxidative stress induces mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines in a well-matched case control cohort. PLoS ONE. 2014;9(1): e85436.","journal-title":"PLoS ONE"},{"key":"600_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2020.113283","volume":"291","author":"BQ Guo","year":"2020","unstructured":"Guo BQ, Li HB, Ding SB. Blood homocysteine levels in children with autism spectrum disorder: an updated systematic review and meta-analysis. Psychiatry Res. 2020;291: 113283.","journal-title":"Psychiatry Res"},{"issue":"6","key":"600_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2013.51","volume":"3","author":"RE Frye","year":"2013","unstructured":"Frye RE, et al. Redox metabolism abnormalities in autistic children associated with mitochondrial disease. Transl Psychiatry. 2013;3(6): e273.","journal-title":"Transl Psychiatry"},{"issue":"6","key":"600_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066418","volume":"8","author":"A Ghezzo","year":"2013","unstructured":"Ghezzo A, et al. Oxidative stress and erythrocyte membrane alterations in children with autism: correlation with clinical features. PLoS ONE. 2013;8(6): e66418.","journal-title":"PLoS ONE"},{"issue":"6","key":"600_CR89","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/acps.13170","volume":"141","author":"BQ Guo","year":"2020","unstructured":"Guo BQ, Ding SB, Li HB. Blood biomarker levels of methylation capacity in autism spectrum disorder: a systematic review and meta-analysis. Acta Psychiatr Scand. 2020;141(6):492\u2013509.","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"600_CR90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005385","volume":"13","author":"DP Howsmon","year":"2017","unstructured":"Howsmon DP, et al. Classification and adaptive behavior prediction of children with autism spectrum disorder based upon multivariate data analysis of markers of oxidative stress and DNA methylation. PLoS Comput Biol. 2017;13(3): e1005385.","journal-title":"PLoS Comput Biol"},{"issue":"2","key":"600_CR91","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/btm2.10095","volume":"3","author":"DP Howsmon","year":"2018","unstructured":"Howsmon DP, et al. Multivariate techniques enable a biochemical classification of children with autism spectrum disorder versus typically-developing peers: a comparison and validation study. Bioeng Transl Med. 2018;3(2):156\u201365.","journal-title":"Bioeng Transl Med."},{"issue":"3","key":"600_CR92","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S0006-3223(98)00337-0","volume":"46","author":"A Alberti","year":"1999","unstructured":"Alberti A, et al. Sulphation deficit in \u201clow-functioning\u201d autistic children: a pilot study. Biol Psychiatry. 1999;46(3):420\u20134.","journal-title":"Biol Psychiatry"},{"key":"600_CR93","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.rasd.2018.09.003","volume":"56","author":"K Hollowood","year":"2018","unstructured":"Hollowood K, et al. Maternal metabolic profile predicts high or low risk of an autism pregnancy outcome. Res Autism Spectr Disord. 2018;56:72\u201382.","journal-title":"Res Autism Spectr Disord"},{"issue":"8","key":"600_CR94","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/jpm11080784","volume":"11","author":"DA Rossignol","year":"2021","unstructured":"Rossignol DA, Frye RE. The effectiveness of cobalamin (B12) treatment for autism spectrum disorder: a systematic review and meta-analysis. J Pers Med. 2021;11(8):784.","journal-title":"J Pers Med."},{"issue":"5","key":"600_CR95","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s40291-018-0352-x","volume":"22","author":"S Rose","year":"2018","unstructured":"Rose S, et al. Clinical and molecular characteristics of mitochondrial dysfunction in autism spectrum disorder. Mol Diagn Ther. 2018;22(5):571\u201393.","journal-title":"Mol Diagn Ther"},{"issue":"3","key":"600_CR96","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/mp.2010.136","volume":"17","author":"DA Rossignol","year":"2012","unstructured":"Rossignol DA, Frye RE. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry. 2012;17(3):290\u2013314.","journal-title":"Mol Psychiatry"},{"issue":"10","key":"600_CR97","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2217\/bmm.15.72","volume":"9","author":"MJ Goldenthal","year":"2015","unstructured":"Goldenthal MJ, et al. Mitochondrial enzyme dysfunction in autism spectrum disorders; a novel biomarker revealed from buccal swab analysis. Biomark Med. 2015;9(10):957\u201365.","journal-title":"Biomark Med"},{"issue":"6","key":"600_CR98","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1007\/s11011-017-0087-0","volume":"32","author":"L Delhey","year":"2017","unstructured":"Delhey L, et al. Bioenergetic variation is related to autism symptomatology. Metab Brain Dis. 2017;32(6):2021\u201331.","journal-title":"Metab Brain Dis"},{"issue":"21","key":"600_CR99","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1001\/jama.2010.1706","volume":"304","author":"C Giulivi","year":"2010","unstructured":"Giulivi C, et al. Mitochondrial dysfunction in autism. JAMA. 2010;304(21):2389\u201396.","journal-title":"JAMA"},{"key":"600_CR100","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fpsyt.2019.00269","volume":"10","author":"SC Bennuri","year":"2019","unstructured":"Bennuri SC, Rose S, Frye RE. Mitochondrial dysfunction is inducible in lymphoblastoid cell lines from children with autism and may involve the TORC1 pathway. Front Psychiatry. 2019;10:269.","journal-title":"Front Psychiatry."},{"issue":"4","key":"600_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2014.15","volume":"4","author":"S Rose","year":"2014","unstructured":"Rose S, et al. Oxidative stress induces mitochondrial dysfunction in a subset of autistic lymphoblastoid cell lines. Transl Psychiatry. 2014;4(4): e377.","journal-title":"Transl Psychiatry"},{"issue":"5","key":"600_CR102","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/acn3.51034","volume":"7","author":"K Singh","year":"2020","unstructured":"Singh K, et al. Developmental regression and mitochondrial function in children with autism. Ann Clin Transl Neurol. 2020;7(5):683\u201394.","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"600_CR103","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1038\/s41380-020-00885-2","volume":"26","author":"RE Frye","year":"2021","unstructured":"Frye RE, et al. Prenatal air pollution influences neurodevelopment and behavior in autism spectrum disorder by modulating mitochondrial physiology. Mol Psychiatry. 2021;26(5):1561\u201377.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"600_CR104","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41398-020-00905-3","volume":"10","author":"RE Frye","year":"2020","unstructured":"Frye RE, et al. Early life metal exposure dysregulates cellular bioenergetics in children with regressive autism spectrum disorder. Transl Psychiatry. 2020;10(1):223.","journal-title":"Transl Psychiatry"},{"key":"600_CR105","doi-asserted-by":"crossref","unstructured":"Legido A, et al. Effect of a combination of carnitine, coenzyme Q10 and alpha-lipoic acid (MitoCocktail) on mitochondrial function and neurobehavioral performance in children with autism spectrum disorder. In: 17th annual meeting of the international society for autism research; 9\u201312 May 2018; Rotterdam.","DOI":"10.1212\/WNL.90.15_supplement.P3.313"},{"issue":"2","key":"600_CR106","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/jcm6020018","volume":"6","author":"LM Delhey","year":"2017","unstructured":"Delhey LM, et al. The effect of mitochondrial supplements on mitochondrial activity in children with autism spectrum disorder. J Clin Med. 2017;6(2):18.","journal-title":"J Clin Med"},{"key":"600_CR107","doi-asserted-by":"crossref","unstructured":"Edmiston E, Ashwood P, Van de Water J. Autoimmunity, autoantibodies, and autism spectrum disorder. Biol Psychiatry. 2017;81(5):383\u201390","DOI":"10.1016\/j.biopsych.2016.08.031"},{"key":"600_CR108","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fncel.2018.00405","volume":"12","author":"HK Hughes","year":"2018","unstructured":"Hughes HK, et al. Immune dysfunction and autoimmunity as pathological mechanisms in autism spectrum disorders. Front Cell Neurosci. 2018;12:405.","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"600_CR109","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3390\/jpm11060488","volume":"11","author":"DA Rossignol","year":"2021","unstructured":"Rossignol DA, Frye RE. A systematic review and meta-analysis of immunoglobulin G abnormalities and the therapeutic use of intravenous Iimunoglobulins (IVIG) in autism spectrum disorder. J Pers Med. 2021;11(6):488.","journal-title":"J Pers Med."},{"issue":"1","key":"600_CR110","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41398-018-0214-7","volume":"8","author":"K Connery","year":"2018","unstructured":"Connery K, et al. Intravenous immunoglobulin for the treatment of autoimmune encephalopathy in children with autism. Transl Psychiatry. 2018;8(1):148.","journal-title":"Transl Psychiatry"},{"issue":"11","key":"600_CR111","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.3390\/jpm11111141","volume":"11","author":"DA Rossignol","year":"2021","unstructured":"Rossignol DA, Frye RE. Cerebral folate deficiency, folate receptor alpha autoantibodies and leucovorin (folinic acid) treatment in autism spectrum disorders: a systematic review and meta-analysis. J Pers Med. 2021;11(11):1141.","journal-title":"J Pers Med."},{"issue":"1","key":"600_CR112","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41398-017-0089-z","volume":"8","author":"S Rose","year":"2018","unstructured":"Rose S, et al. Butyrate enhances mitochondrial function during oxidative stress in cell lines from boys with autism. Transl Psychiatry. 2018;8(1):42.","journal-title":"Transl Psychiatry"},{"issue":"2","key":"600_CR113","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/mp.2016.77","volume":"22","author":"KL Jones","year":"2017","unstructured":"Jones KL, et al. Autism with intellectual disability is associated with increased levels of maternal cytokines and chemokines during gestation. Mol Psychiatry. 2017;22(2):273\u20139.","journal-title":"Mol Psychiatry"},{"issue":"5","key":"600_CR114","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.biopsych.2015.08.007","volume":"81","author":"P Krakowiak","year":"2017","unstructured":"Krakowiak P, et al. Neonatal cytokine profiles associated with autism spectrum disorder. Biol Psychiatry. 2017;81(5):442\u201351.","journal-title":"Biol Psychiatry"},{"issue":"4","key":"600_CR115","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/mp.2014.59","volume":"20","author":"A Masi","year":"2015","unstructured":"Masi A, et al. Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. Mol Psychiatry. 2015;20(4):440\u20136.","journal-title":"Mol Psychiatry"},{"issue":"19","key":"600_CR116","doi-asserted-by":"publisher","first-page":"4731","DOI":"10.3390\/ijms20194731","volume":"20","author":"H Jyonouchi","year":"2019","unstructured":"Jyonouchi H, Geng L. Associations between monocyte and T cell cytokine profiles in autism spectrum disorders: effects of dysregulated innate immune responses on adaptive responses to recall antigens in a subset of ASD Children. Int J Mol Sci. 2019;20(19):4731.","journal-title":"Int J Mol Sci"},{"key":"600_CR117","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12974-014-0187-2","volume":"11","author":"H Jyonouchi","year":"2014","unstructured":"Jyonouchi H, Geng L, Davidow AL. Cytokine profiles by peripheral blood monocytes are associated with changes in behavioral symptoms following immune insults in a subset of ASD subjects: an inflammatory subtype? J Neuroinflamm. 2014;11:187.","journal-title":"J Neuroinflamm"},{"issue":"1","key":"600_CR118","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12974-017-1003-6","volume":"14","author":"H Jyonouchi","year":"2017","unstructured":"Jyonouchi H, et al. MicroRNA expression changes in association with changes in interleukin-1ss\/interleukin10 ratios produced by monocytes in autism spectrum disorders: their association with neuropsychiatric symptoms and comorbid conditions (observational study). J Neuroinflamm. 2017;14(1):229.","journal-title":"J Neuroinflamm"},{"key":"600_CR119","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3389\/fpsyt.2019.00614","volume":"10","author":"H Jyonouchi","year":"2019","unstructured":"Jyonouchi H, et al. Serum microRNAs in ASD: association with monocyte cytokine profiles and mitochondrial respiration. Front Psychiatry. 2019;10:614.","journal-title":"Front Psychiatry."},{"key":"600_CR120","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3389\/fpsyt.2019.00071","volume":"10","author":"H Jyonouchi","year":"2019","unstructured":"Jyonouchi H, et al. Variations in mitochondrial respiration differ in IL-1ss\/IL-10 ratio based subgroups in autism spectrum disorders. Front Psychiatry. 2019;10:71.","journal-title":"Front Psychiatry."},{"issue":"6","key":"600_CR121","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/aur.2104","volume":"12","author":"R Thapa","year":"2019","unstructured":"Thapa R, et al. Reduced heart rate variability in adults with autism spectrum disorder. Autism Res. 2019;12(6):922\u201330.","journal-title":"Autism Res"},{"issue":"11","key":"600_CR122","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1007\/s10803-020-04458-8","volume":"50","author":"C Lory","year":"2020","unstructured":"Lory C, et al. Brief report: reduced heart rate variability in children with autism spectrum disorder. J Autism Dev Disord. 2020;50(11):4183\u201390.","journal-title":"J Autism Dev Disord"},{"key":"600_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2021.104034","volume":"116","author":"CN Gonzaga","year":"2021","unstructured":"Gonzaga CN, et al. Autonomic responses to facial expression tasks in children with autism spectrum disorders: cross-section study. Res Dev Disabil. 2021;116: 104034.","journal-title":"Res Dev Disabil"},{"issue":"7","key":"600_CR124","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3390\/medicina55070346","volume":"55","author":"R Bharath","year":"2019","unstructured":"Bharath R, et al. Comparison of physiological and biochemical autonomic indices in children with and without autism spectrum disorders. Medicina (Kaunas). 2019;55(7):346.","journal-title":"Medicina (Kaunas)"},{"issue":"6","key":"600_CR125","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1080\/13803395.2016.1252724","volume":"39","author":"RM Zamzow","year":"2017","unstructured":"Zamzow RM, et al. Effects of acute beta-adrenergic antagonism on verbal problem solving in autism spectrum disorder and exploration of treatment response markers. J Clin Exp Neuropsychol. 2017;39(6):596\u2013606.","journal-title":"J Clin Exp Neuropsychol"},{"key":"600_CR126","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.neubiorev.2020.09.032","volume":"120","author":"L de Vries","year":"2021","unstructured":"de Vries L, et al. Autism spectrum disorder and pupillometry: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2021;120:479\u2013508.","journal-title":"Neurosci Biobehav Rev"},{"key":"600_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtemb.2021.126782","volume":"67","author":"J Zhang","year":"2021","unstructured":"Zhang J, et al. Trace elements in children with autism spectrum disorder: a meta-analysis based on case-control studies. J Trace Elem Med Biol. 2021;67: 126782.","journal-title":"J Trace Elem Med Biol"},{"key":"600_CR128","doi-asserted-by":"publisher","first-page":"15493","DOI":"10.1038\/ncomms15493","volume":"8","author":"M Arora","year":"2017","unstructured":"Arora M, et al. Fetal and postnatal metal dysregulation in autism. Nat Commun. 2017;8:15493.","journal-title":"Nat Commun"},{"issue":"5","key":"600_CR129","doi-asserted-by":"publisher","first-page":"eaat1293","DOI":"10.1126\/sciadv.aat1293","volume":"4","author":"P Curtin","year":"2018","unstructured":"Curtin P, et al. Dynamical features in fetal and postnatal zinc-copper metabolic cycles predict the emergence of autism spectrum disorder. Sci Adv. 2018;4(5):eaat1293.","journal-title":"Sci Adv"},{"key":"600_CR130","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jpsychores.2016.08.013","volume":"89","author":"J Chen","year":"2016","unstructured":"Chen J, et al. Lower maternal serum 25(OH) D in first trimester associated with higher autism risk in Chinese offspring. J Psychosom Res. 2016;89:98\u2013101.","journal-title":"J Psychosom Res"},{"issue":"2","key":"600_CR131","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1192\/bjpo.bp.116.004077","volume":"3","author":"AAE Vinkhuyzen","year":"2017","unstructured":"Vinkhuyzen AAE, et al. Gestational vitamin D deficiency and autism spectrum disorder. BJPsych Open. 2017;3(2):85\u201390.","journal-title":"BJPsych Open."},{"issue":"2","key":"600_CR132","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1192\/bjpo.bp.116.002675","volume":"2","author":"C Magnusson","year":"2016","unstructured":"Magnusson C, et al. Maternal vitamin D deficiency and the risk of autism spectrum disorders: population-based study. BJPsych Open. 2016;2(2):170\u20132.","journal-title":"BJPsych Open."},{"key":"600_CR133","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.reprotox.2015.05.007","volume":"56","author":"A Ornoy","year":"2015","unstructured":"Ornoy A, Weinstein-Fudim L, Ergaz Z. Prenatal factors associated with autism spectrum disorder (ASD). Reprod Toxicol. 2015;56:155\u201369.","journal-title":"Reprod Toxicol"},{"issue":"2","key":"600_CR134","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1001\/jamapsychiatry.2017.4050","volume":"75","author":"SZ Levine","year":"2018","unstructured":"Levine SZ, et al. Association of maternal use of folic acid and multivitamin supplements in the periods before and during pregnancy with the risk of autism spectrum disorder in offspring. JAMA Psychiat. 2018;75(2):176\u201384.","journal-title":"JAMA Psychiat"},{"issue":"1","key":"600_CR135","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/ppe.12414","volume":"32","author":"R Raghavan","year":"2018","unstructured":"Raghavan R, et al. Maternal multivitamin intake, plasma folate and vitamin B12 levels and autism spectrum disorder risk in offspring. Paediatr Perinat Epidemiol. 2018;32(1):100\u201311.","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"1","key":"600_CR136","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13229-020-0315-z","volume":"11","author":"O Egorova","year":"2020","unstructured":"Egorova O, et al. Maternal blood folate status during early pregnancy and occurrence of autism spectrum disorder in offspring: a study of 62 serum biomarkers. Mol Autism. 2020;11(1):7.","journal-title":"Mol Autism."},{"issue":"8","key":"600_CR137","doi-asserted-by":"publisher","first-page":"687","DOI":"10.2217\/bmm-2017-0109","volume":"11","author":"RE Frye","year":"2017","unstructured":"Frye RE, Slattery JC, Quadros EV. Folate metabolism abnormalities in autism: potential biomarkers. Biomark Med. 2017;11(8):687\u201399.","journal-title":"Biomark Med"},{"issue":"5","key":"600_CR138","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/metabo12050371","volume":"12","author":"D Brister","year":"2022","unstructured":"Brister D, et al. Central nervous system metabolism in autism, epilepsy and developmental delays: a cerebrospinal fluid analysis. Metabolites. 2022;12(5):371.","journal-title":"Metabolites"},{"issue":"1","key":"600_CR139","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3390\/jpm11010041","volume":"11","author":"AG Mesleh","year":"2021","unstructured":"Mesleh AG, Abdulla SA, El-Agnaf O. Paving the way toward personalized medicine: current advances and challenges in multi-OMICS approach in autism spectrum disorder for biomarkers discovery and patient stratification. J Pers Med. 2021;11(1):41.","journal-title":"J Pers Med."},{"issue":"6","key":"600_CR140","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.3390\/nu13061849","volume":"13","author":"JB Adams","year":"2021","unstructured":"Adams JB, et al. Evidence-based recommendations for an optimal prenatal supplement for women in the U.S., part two: minerals. Nutrients. 2021;13(6):1849.","journal-title":"Nutrients"},{"key":"600_CR141","volume-title":"The science behind the healthy child guide","author":"JB Adams","year":"2020","unstructured":"Adams JB, et al. The science behind the healthy child guide. Dallas: Neurological Health Foundation; 2020."},{"key":"600_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.spen.2020.100831","volume":"35","author":"P McCarty","year":"2020","unstructured":"McCarty P, Frye RE. Early detection and diagnosis of autism spectrum disorder: why is it so difficult? Semin Pediatr Neurol. 2020;35: 100831.","journal-title":"Semin Pediatr Neurol."}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-022-00600-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-022-00600-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-022-00600-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T21:43:19Z","timestamp":1727473399000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40291-022-00600-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,27]]},"references-count":142,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["600"],"URL":"https:\/\/doi.org\/10.1007\/s40291-022-00600-7","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,27]]},"assertion":[{"value":"16 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was funded, in part, by the Brain Foundation (Pleasanton, CA), the O\u2019Sullivan foundation (Princeton, NJ), the N of 1 Foundation (Dallas TX), The Jonty Foundation (St Paul, MN), the Gupta Family Foundation (Atherton, CA), and the Jager Family Foundation (Chicago, IL).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Richard E. Frye is funded by the National Institutes of Health, Department of Defense, and Autism Speaks and receives support from the Turnabout for Autism, the Brain Foundation, the\u00a0Autism Research Institute and Zynerba Pharmaceuticals. He is on the advisory boards of Iliad Neurosciences and NeuroNeeds. The remaining authors declare that they have no conflicts of interest that are directly relevant to the contents of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors are accountable for all aspects of the work, including full data access, integrity of the data, and the accuracy of the data analysis. All authors will ensure that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All the authors contributed to the study conception and design. The first draft of the manuscript was written by all the authors. All the authors read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}